Fast Market Research

Neurotec Pharma SL - Product Pipeline Review - 2013 - New Market Research Report

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

 

Boston, MA -- (ReleaseWire) -- 02/03/2014 -- Global Market Direct's pharmaceuticals report, "Neurotec Pharma SL - Product Pipeline Review - 2013" provides data on the Neurotec Pharma SL's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Neurotec Pharma SL's corporate website, SEC filings, investor presentations and featured press releases, both from Neurotec Pharma SL and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Neurotec Pharma SL - Brief Neurotec Pharma SL overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Neurotec Pharma SL human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Neurotec Pharma SL with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Neurotec Pharma SL's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Neurotec Pharma SL's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Neurotec Pharma SL in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Neurotec Pharma SL's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Neurotec Pharma SL.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Neurotec Pharma SL and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Neurotec Pharma SL - Product Pipeline Review - 2012
- Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2013
- Dr. Falk Pharma GmbH - Product Pipeline Review - 2013
- Dainippon Sumitomo Pharma Co., Ltd. - Product Pipeline Review - 2013
- Mitsubishi Tanabe Pharma Corporation - Product Pipeline Review - 2013
- Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2013
- Dong-A Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- LEO Pharma A/S - Product Pipeline Review - 2013
- Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013
- Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2013